| 3 | 1/1 | 返回列表 |
| 查看: 859 | 回復(fù): 2 | |||
| 本帖產(chǎn)生 1 個(gè) 翻譯EPI ,點(diǎn)擊這里進(jìn)行查看 | |||
jinchunlan新蟲(chóng) (初入文壇)
|
[交流]
求把這一段中文翻譯成英語(yǔ)
|
||
| 溫陽(yáng)方由溫陽(yáng)利水法化裁而來(lái),是王老經(jīng)長(zhǎng)期臨床實(shí)踐總結(jié)的慢性心衰中藥復(fù)方制劑。前期臨床和實(shí)驗(yàn)研究證實(shí)該方具有良好的臨床療效,能夠改善心力衰竭動(dòng)物模型心肌重塑。隨著慢性心力衰竭研究進(jìn)展的不斷深入,細(xì)胞因子網(wǎng)絡(luò)在心力衰竭心肌重構(gòu)中的作用日益引起廣泛關(guān)注。其中腫瘤壞死因子α(Tumor necrosis factorα,TNFα) 是重要的促炎性細(xì)胞因子,作為激活細(xì)胞級(jí)聯(lián)反應(yīng)的主要介質(zhì),在細(xì)胞因子網(wǎng)絡(luò)中發(fā)揮關(guān)鍵作用。核轉(zhuǎn)錄因子-κB (nuclear factor κB,NF-κB)是調(diào)控多種基因轉(zhuǎn)錄的關(guān)鍵因子,活化后能調(diào)控包括TNFα在內(nèi)的多種炎癥介質(zhì)的轉(zhuǎn)錄,作為炎性反應(yīng)的整合者在免疫調(diào)節(jié)和炎癥發(fā)生過(guò)程中具有重要作用。為進(jìn)一步探討溫陽(yáng)方藥效和作用機(jī)理,明確NF-κB在心衰發(fā)病中的作用及對(duì)TNFα調(diào)節(jié)機(jī)制,本研究采用細(xì)胞培養(yǎng)和血清藥理學(xué)方法,開(kāi)展溫陽(yáng)方對(duì)腫瘤壞死因子α(TNFα)誘導(dǎo)新生大鼠心肌成纖維細(xì)胞(cardial fibroblasts CFs)增殖、膠原合成,及核轉(zhuǎn)錄因子NF-κB表達(dá)的影響,進(jìn)一步從分子水平探討其抑制心肌纖維化,改善心力衰竭心肌重塑的作用機(jī)制,從而為其臨床應(yīng)用及新藥開(kāi)發(fā)提供科學(xué)理論和依據(jù)。 |
新蟲(chóng) (小有名氣)
| By the WenYangFang WenYangLi water cut and come, is the long-term clinical practice cenwanglaoshan herbal preparations of chronic heart failure. The clinical and experimental research confirms the party has good curative effect, can improve cardiac remodeling animal model for heart failure. With chronic heart failure, research progress of the cytokine network in hf myocardial reconstruction is aroused widespread concern. Among Tumor necrosis factor alpha (Tumor necrosis, TNF alpha) in alpha is an important factor of inflammatory cells, promote cell activation cascade as the main medium, in cytokines play an important role in network. Transcription factor - κ B (nuclear κ B, NF - in κ B) is the regulation of gene transcription factors, activate the key to control including TNF alpha, inflammation, as the transcription of integration of the inflammatory response in immune adjustment and inflammation plays an important role in the process. For further discussion WenYangFang efficacy and mechanism, clear in heart failure κ B NF - the role and pathogenesis of TNF alpha adjusting mechanism, this study adopts cell culture and serum pharmacology, WenYangFang method of tumor necrosis factor (TNF alpha) inducing newborn rat cardiac fibroblasts cardial (CFs) proliferation, fibroblasts collagen synthesis, and κ transcription factor NF - expression of B, further discusses its suppression of the molecular myocardial fibrosis, improve cardiac remodeling of heart failure mechanism, so as to its clinical application and development of new medicine to provide scientific theory and evidence. |
新蟲(chóng) (小有名氣)
| 3 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 一志愿華南師大 070300(化學(xué))304分求調(diào)劑 +3 | 0703武芊慧雪304 2026-03-18 | 3/150 |
|
|---|---|---|---|---|
|
[考研] 一志愿西南交大,求調(diào)劑 +5 | 材化逐夢(mèng)人 2026-03-18 | 5/250 |
|
|
[考研] 22408 344分 求調(diào)劑 一志愿 華電計(jì)算機(jī)技術(shù) +4 | solanXXX 2026-03-20 | 4/200 |
|
|
[考研] 一志愿中海洋材料工程專(zhuān)碩330分求調(diào)劑 +8 | 小材化本科 2026-03-18 | 8/400 |
|
|
[考研] 288求調(diào)劑 +16 | 于海海海海 2026-03-19 | 16/800 |
|
|
[考研] 317求調(diào)劑 +5 | 申子申申 2026-03-19 | 9/450 |
|
|
[考研] 一志愿中南化學(xué)(0703)總分337求調(diào)劑 +8 | niko- 2026-03-19 | 9/450 |
|
|
[考研] 0817 化學(xué)工程 299分求調(diào)劑 有科研經(jīng)歷 有二區(qū)文章 +22 | rare12345 2026-03-18 | 22/1100 |
|
|
[考研] 319求調(diào)劑 +3 | 小力氣珂珂 2026-03-20 | 3/150 |
|
|
[考研] 298-一志愿中國(guó)農(nóng)業(yè)大學(xué)-求調(diào)劑 +9 | 手機(jī)用戶 2026-03-17 | 9/450 |
|
|
[考博] 招收博士1-2人 +3 | QGZDSYS 2026-03-18 | 3/150 |
|
|
[考研] 能源材料化學(xué)課題組招收碩士研究生8-10名 +5 | 脫穎而出 2026-03-16 | 14/700 |
|
|
[考研] 307求調(diào)劑 +9 | 冷笙123 2026-03-17 | 9/450 |
|
|
[考研] 288求調(diào)劑,一志愿華南理工大學(xué)071005 +5 | ioodiiij 2026-03-17 | 5/250 |
|
|
[考研] 化學(xué)求調(diào)劑 +3 | 臨澤境llllll 2026-03-17 | 4/200 |
|
|
[考研] 材料考研調(diào)劑 +3 | xwt。 2026-03-19 | 3/150 |
|
|
[考研] 311求調(diào)劑 +6 | 26研0 2026-03-15 | 6/300 |
|
|
[考研] 301求調(diào)劑 +4 | A_JiXing 2026-03-16 | 4/200 |
|
|
[考研] 考研化學(xué)學(xué)碩調(diào)劑,一志愿985 +4 | 張vvvv 2026-03-15 | 6/300 |
|
|
[考研] 復(fù)試調(diào)劑 +3 | 呼呼?~+123456 2026-03-14 | 3/150 |
|